Advertisement
Screener

Endurant Capital Management LP Historic Quarter Change: Foreign Stocks, Added

Endurant Capital Management LP historic quarter change: Foreign Stocks, Added

In share positions in stocks (depositary receipts and foreign shares traded over the counter), over 8 quarters from 2014-12-31 to 2024-03-31, Endurant Capital Management LP opened 0 positions, added to 4, reduced 6 and sold out of 3.

  • Q4 2015: Stock TEVA; Country of operation —; Class ADR; Shares before 233,100.
  • Q3 2015: Stock TEVA; Country of operation —; Class ADR; Shares before 188,800.
  • Q2 2015: Stock TEVA; Country of operation —; Class ADR; Shares before 179,500.
  • Q1 2015: Stock TEVA; Country of operation —; Class ADR; Shares before 132,900.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1633055), 8 quarters: Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-07); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-15); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-15); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-16); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-16); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2014-12-31. Not compared, as a quarter between them is not held here yet: 2016-09-30 to 2023-12-31 (missing 2016-12-31, 2017-03-31, 2017-06-30, 2017-09-30, 2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31, 2019-06-30, 2019-09-30, 2019-12-31, 2020-03-31, 2020-06-30, 2020-09-30, 2020-12-31, 2021-03-31, 2021-06-30, 2021-09-30, 2021-12-31, 2022-03-31, 2022-06-30, 2022-09-30, 2022-12-31, 2023-03-31, 2023-06-30, 2023-09-30).

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q4 2015TEVA
TEVA PHARMACEUTICAL INDS LTD
ADR233,100330,033+96,933$13,161,000$21,663,000+$8,502,0002016-02-16
Q3 2015TEVA
TEVA PHARMACEUTICAL INDS LTD
ADR188,800233,100+44,300$11,158,000$13,161,000+$2,003,0002015-11-16
Q2 2015TEVA
TEVA PHARMACEUTICAL INDS LTD
ADR179,500188,800+9,300$11,183,000$11,158,000-$25,0002015-08-14
Q1 2015TEVA
TEVA PHARMACEUTICAL INDS LTD
ADR132,900179,500+46,600$7,643,000$11,183,000+$3,540,0002015-05-15

Similar Firms

Firm NameCountry13F ValueHoldings
Not available yet